Tag: EcoR1

Can hybrid bentgrass provide dollar spot resistance, drought tolerance?

This interspecific hybrid population is a cross between colonial bentgrass BCD and creeping bentgrass Providence, grown in a greenhouse. Photo by Jinyoung Y. Barnaby Colonial bentgrass is a turfgrass species that can be established on grass tennis courts and golf course fairways and used for erosion control (8). Colonial bentgrasses…

Continue Reading Can hybrid bentgrass provide dollar spot resistance, drought tolerance?

The Age of Aquarius – RNA, the Epicenter of Genetic Information

The veil on genetic information was lifted by the advent of gene cloning and sequencing technologies in the 1970s. The discovery and purification of bacterial nucleases capable of cutting DNA at specific sequences and ligases capable of joining them enabled DNA from any species – or mRNAs converted to complementary…

Continue Reading The Age of Aquarius – RNA, the Epicenter of Genetic Information

Characterizing the regulatory Fas (CD95) epitope critical for agonist antibody targeting and CAR-T bystander function in ovarian cancer

Mice strains Six- to eight-week-old (age), 20–25-g (weight), both male and female (sex) mice were used for tumor xenografts generation and in vivo efficacy studies as described in the text (see Table 3). Athymic Nude (Envigo) Foxn1nu/Foxn1+ or NOD.Cg Prkdcscid Il2rgtm1Wjl/SzJ also called NSG mice were used. All animal procedures were…

Continue Reading Characterizing the regulatory Fas (CD95) epitope critical for agonist antibody targeting and CAR-T bystander function in ovarian cancer

Solved You are trying to clone a ribosomal 16 s rRNA gene

Transcribed image text: You are trying to clone a ribosomal 16 s rRNA gene fragment from soil bacteria that has been PCR amplified. This is the resulting image after electrophoresis. Match up the type of DNA to the corresponding letter (letters are positioned just to the right of the corresponding stained…

Continue Reading Solved You are trying to clone a ribosomal 16 s rRNA gene

AAD Reading Room | After Latest Findings, FDA Approval for Lebrikizumab Could Happen This Fall

Most patients with moderate-to-severe atopic dermatitis (AD) who received lebrikizumab (Adbry) every 2 weeks maintained a favorable response to the drug out to the 1-year mark, recent trial data showed. Perhaps just as importantly, people receiving the drug every 4 weeks maintained a substantial response, suggesting less-frequent treatments are required…

Continue Reading AAD Reading Room | After Latest Findings, FDA Approval for Lebrikizumab Could Happen This Fall

Senior Biostatistician, Statistical Genetics job with Actio BioSciences, Inc

About Us! Actio Biosciences, Inc., is a drug discovery and development company grounded in the science of precision medicine. Actio is developing a portfolio of drugs to modulate the activity of proteins responsible for rare diseases with the goal to also translate these findings into treatments for common diseases with…

Continue Reading Senior Biostatistician, Statistical Genetics job with Actio BioSciences, Inc

Platelet factors attenuate inflammation and rescue cognition in ageing

Animal models The C57BL/6 mouse line was used for all of the experiments (The Jackson Laboratory and National Institutes of Aging). Homozygous Pf4-KO mice were previously generated and characterized as described48. Pf4-KO mice were a gift from M. Anna Kowalska. Heterozygous mice were bred to generate Pf4-KO and WT littermate…

Continue Reading Platelet factors attenuate inflammation and rescue cognition in ageing

Bioinformatics Scientist – Actio Biosciences, Inc

Job Details Bioinformatics Scientist Job Code #: 23INF-4SBIStatus: Exempt, Full TimeReports to: VP, Genetics and BioinformaticsDepartment: InformaticsContact: careers@actiobio.com About Us! Actio Biosciences, Inc., is a drug discovery and development company grounded in the science of precision medicine. Actio is developing a portfolio of drugs to modulate the activity of proteins…

Continue Reading Bioinformatics Scientist – Actio Biosciences, Inc

Cell And Gene Therapy Company Raises $401 Million In Series D

ElevateBio – a technology-driven company focused on powering the creation of life-transforming cell and gene therapies – announced recently the closing of its $401 million Series D financing led by the AyurMaya Capital Management Fund, managed by Matrix Capital Management, and joined by a leading group of new and existing…

Continue Reading Cell And Gene Therapy Company Raises $401 Million In Series D

ElevateBio raises $401M for cell and gene therapies

ElevateBio, LLC (ElevateBio), a technology-driven company focused on cell and gene therapies, has closed its $401 million Series D financing. “We have made significant strides in scaling our technologies and end-to-end capabilities in our pursuit to become the world’s most indispensable cell and gene therapy technology company. We are thrilled…

Continue Reading ElevateBio raises $401M for cell and gene therapies

DNA double-strand break-free CRISPR interference delays Huntington’s disease progression in mice

Plasmids LentiCRISPRv2 (Addgene; 52961) was purchased from Addgene (Cambridge, MA, USA). For HTT gene suppression, LentiCRISPR v2 plasmid with U6 promoter driving sgRNA expression and EF-1 alpha promoter driving the expression of Puromycin-T2A-HA-NLS-dCas9-NLS (or Puromycin-T2A-Flag-NLS-Cas9-NLS) was used. The sgRNA-Cas9 and sgRNA-dCas9 constructs were generated by cloning the CAG repeat-targeting sgRNA…

Continue Reading DNA double-strand break-free CRISPR interference delays Huntington’s disease progression in mice

Solved You are trying to clone a ribosomal 16s rRNA gene

Transcribed image text: You are trying to clone a ribosomal 16s rRNA gene fragment from soil bacteria that has been PCR amplified. This is the resulting image after electrophoresis. Match up the type of DNA to the corresponding letter (letters are positioned just to the right of the corresponding stained…

Continue Reading Solved You are trying to clone a ribosomal 16s rRNA gene

If a long linear dsDNA having blunt ends with 5’GAATTC3′ 3’CTTAGG5′ sequences at four places is cleaved by using EcoR1, how many DNA fragments are formed with cohesive ends on both sides? 1)5 2)4 3)3 4)2?

Question Description If a long linear dsDNA having blunt ends with 5’GAATTC3′ 3’CTTAGG5′ sequences at four places is cleaved by using EcoR1, how many DNA fragments are formed with cohesive ends on both sides? 1)5 2)4 3)3 4)2? for NEET 2022 is part of NEET preparation. The Question and…

Continue Reading If a long linear dsDNA having blunt ends with 5’GAATTC3′ 3’CTTAGG5′ sequences at four places is cleaved by using EcoR1, how many DNA fragments are formed with cohesive ends on both sides? 1)5 2)4 3)3 4)2?

chloramphenicol resistance

Using these strains, it is possible to integrate plasmids that carry the complementary ΦC31 att site onto the chromosome (attP, in this figure). Because the mtDNA codes for key OXPHOS polypeptides, genetic alterations in the mtDNA will affect energy metabolism. Proc Natl Acad Sci U S A. 1969 Jun;98(3):1248-57 eCollection…

Continue Reading chloramphenicol resistance

Computational Biologist at Chinook Therapeutics

Apply here Chinook Therapeutics Job Description: Computational Biologist Company: Chinook Therapeutics is a clinical-stage biotechnology company developing precision medicines for patients with kidney diseases. We apply our proprietary research platform to discover and develop therapeutics with novel mechanisms of action against key kidney disease pathways. Our development focus is on…

Continue Reading Computational Biologist at Chinook Therapeutics